Movement Alert|Oklo Inc. Rises 5.9% in Regular Trading, DOE Approval of Aurora Powerhouse Safety Analysis Continues to Boost Shares

Market Focus
Jun 15

On June 15, Oklo Inc. rose 5.9% in regular trading, trading at approximately $60.21 per share, with turnover of $200 million. The rally was driven by continued positive sentiment following the U.S. Department of Energy's approval of the preliminary documented safety analysis (PDSA) for Oklo's Aurora powerhouse at Idaho National Laboratory.

The DOE's Idaho Operations Office formally approved the PDSA on June 11 under the Reactor Pilot Program. The analysis covers hazard analysis, accident analysis, safety controls, and design commitments — representing a critical regulatory milestone that clears a major obstacle for subsequent construction permits. This approval validates the initial safety feasibility of the Aurora advanced fission power plant design.

Additionally, Oklo completed its acquisition of precision manufacturing firm ARMEC on June 4, strengthening its vertical integration strategy. Wedbush Securities reiterated an outperform rating with a $110 price target, citing ARMEC's positive free cash flow and complementary capabilities enhancing Oklo's margin profile. UBS adjusted its target to $55, maintaining a neutral rating, while FactSet consensus shows a mean target of $88.26.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10